Skip to main content
SOLARA ACTIVE PHARMA SCIENCES LIMITED logo

SOLARA ACTIVE PHARMA SCIENCES LIMITED - Investor Relations & Filings

Listed IPO Jun 2018
Ticker · SOLARA ISIN · INE624Z01016 LEI · 3358008SUKH3YE2F7F81 BSE.NS Manufacturing
Open in API
Filings indexed 729 across all filing types
Latest filing 2026-07-24 Report Publication Anno…
Country IN India
Listing BSE.NS SOLARA · 2 venues

Key figures FY2026

Period ended 2026-03-31 · INR
Headline annual figures for SOLARA ACTIVE PHARMA SCIENCES LIMITED, fiscal year 2026, reported in INR, with the source filing for each figure.
Total Revenues INR 13.75B per the Earnings Release filed 2026-05-15
Net Income INR -74.00M per the Earnings Release filed 2026-05-15
Total Assets INR 22.77B per the Audit Report / Information filed 2026-05-15
Total Equity INR 12.55B per the Audit Report / Information filed 2026-05-15
Cash from Ops INR 1.53B per the Audit Report / Information filed 2026-05-15

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About SOLARA ACTIVE PHARMA SCIENCES LIMITED

https://www.solara.co.in/

Solara Active Pharma Sciences Limited is a customer-centric organization specializing in the development and manufacturing of active pharmaceutical ingredients (APIs). The company offers a diverse portfolio of high-quality products across therapeutic categories such as pain management, central nervous system, and anti-infectives. It operates several manufacturing sites and research centers that comply with global regulatory standards, including the USFDA and EUGMP. Beyond its commercial API catalog, the company provides comprehensive contract development and manufacturing organization (CDMO) services, assisting partners from the initial research phase to large-scale production. Known for its significant production capacity in key molecules like Ibuprofen, the company focuses on delivering complex and niche APIs to global markets through advanced technical expertise and a commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a filing letter and an attached copy of a newspaper advertisement regarding the publication of unaudited financial results for the quarter ended June 30, 2026. According to the Menu vs Meal rule, publishing a notice that financial results or reports have been published in newspapers or are available on the website falls under Report Publication Announcement (RPA).
2026-07-24 English
Solara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) ....
Report Publication Announcement Classification · 95% confidence The document is a letter from Solara Active Pharma Sciences Limited to the stock exchanges (BSE and NSE) informing them about the publication of newspaper advertisements containing extracts of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026. According to the Menu vs Meal rule, since this is a notice/announcement informing the exchanges that financial results have been published in newspapers and providing copies of those advertisements rather than the comprehensive interim financial report itself, it falls under Report Publication Announcement (RPA).
2026-07-24 English
Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30, 2026
Interim / Quarterly Report Classification · 98% confidence The document contains the comprehensive unaudited interim financial results (both standalone and consolidated) for Solara Active Pharma Sciences Limited for the quarter ended June 30, 2026, accompanied by the independent auditor's review report from Deloitte Haskins & Sells LLP and explanatory notes. Because it includes the complete financial statements and performance tables for a period shorter than a full fiscal year, it is classified as an Interim / Quarterly Report (IR). Q1 2027
2026-07-24 English
Updates
Regulatory Filings
2026-07-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 95% confidence The document is a short notification (1547 characters) informing stock exchanges about the upload of audio recordings of the Q1 FY27 earnings call. It is not the full verbatim transcript itself, nor is it the earnings release or financial report. According to the Menu vs Meal rule, announcements of calls, recordings, or published reports fall under Report Publication Announcement (RPA).
2026-07-23 English
Solara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23, 2026, at 16.00 IST
Regulatory Filings Classification · 85% confidence The document is a short regulatory notification informing the stock exchanges (BSE and NSE) that the audio recording of the Q1 FY27 earnings call has been uploaded to the company's website. It provides the link to the audio recording. It is not the full transcript of the call itself, nor is it the earnings release or financial report. According to the classification guidelines and the Menu vs Meal rule, announcements regarding the release of call recordings or investor events fall under Report Publication Announcement (RPA) or Regulatory Filings (RNS). Specifically, notifying the exchange about earnings call audio recordings fits best as a regulatory disclosure/announcement or RPA. Let's evaluate RPA: 'Announcement regarding the timing, release, or publication of company reports... Also covers announcements inviting stakeholders to an upcoming results call, webcast, or investor presentation.' Alternatively, general regulatory compliance and notifications fall under RNS. Since it is a routine regulatory stock exchange communication about an event recording, RNS (Regulatory Filings) or RPA are both candidates, but RNS is the standard fallback for general exchange notifications that are not reports, dividends, or direct material events. Let's double check if RNS is the best fit. Regulatory filings cover compliance documents and miscellaneous filings. Let's use RNS.
2026-07-23 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.